ST6GAL1 and cancer: Previous studies have shown ST6GAL1-mediated α2-6 sialylation impacts cancer hallmarks and regulates oncogenic cell behaviours, however the specific targets and signalling pathways orchestrated by ST6GAL1 require greater delineation.17